How China Inc. Aims To Take Over Cell Therapy Dominance

Speed, Partnerships Shine for Small CAR-T Players

 
• By Brian Yang
Nanjing, China
NANJING-BASED IASO, SET UP IN 2017, AIMS TO FILE ITS CAR-T THERAPY NEXT YEAR IN CHINA • Source: Shutterstock

More from Gene Therapies

More from Advanced Therapies